A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery
Study sponsor: Arvinas Inc. · ARVN
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2024-07-13Actual
Enrollment · participants152Actual
Source updated2025-08-29Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.